Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.35 is 25% below its 5-year average of 7.14, near the low end of its 5-year range (5.07–23.19).
As of the fiscal period ended Tuesday, June 30, 2026. 15.59% below its 12-month average of 6.33.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.35.
QUICK RATIO (ACID-TEST)
5.35
QUICK RATIO (ACID-TEST) AVG TTM
6.33
QUICK RATIO (ACID-TEST) AVG 3Y
6.64
QUICK RATIO (ACID-TEST) AVG 5Y
7.14
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.59%
CURRENT VS 3Y AVG
-19.46%
CURRENT VS 5Y AVG
-25.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+59.60%
vs the sector median at left
PROCEPT BioRobotics Corporation
Market Cap
$994.10M
Quick Ratio (Acid-Test)
5.35
TTM Avg
6.33
3Y Avg
6.64
5Y Avg
7.14
Market Cap
$998.37M
Quick Ratio (Acid-Test)
19.15
TTM Avg
11.70
3Y Avg
12.62
5Y Avg
12.74
Market Cap
$988.62M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.37M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.39
3Y Avg
1.76
5Y Avg
2.46
Market Cap
$979.88M
Quick Ratio (Acid-Test)
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$1.01B
Quick Ratio (Acid-Test)
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$972.75M
Quick Ratio (Acid-Test)
3.94
TTM Avg
2.64
3Y Avg
3.04
5Y Avg
2.66
Market Cap
$1.02B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.12
3Y Avg
6.56
5Y Avg
10.14
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $994.10M | 5.35 | 6.33 | 6.64 | 7.14 |
| Vor Biopharma Inc. (VOR)vs › | $998.37M | 19.15 | 11.70 | 12.62 | 12.74 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $988.62M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $985.37M | 3.76 | 1.39 | 1.76 | 2.46 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.88M | 15.08 | 22.50 | 27.08 | 27.08 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | 8.42 | 11.89 | 15.48 | 17.00 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| Pacira BioSciences, Inc. (PCRX)vs › | $972.75M | 3.94 | 2.64 | 3.04 | 2.66 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | 5.85 | 6.12 | 6.56 | 10.14 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | 16.35 | 49.13 | 36.31 | 29.96 |
Quick Ratio
5.35
Excludes inventory
Current Ratio
6.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.35 |
| 2026-03-31 | 5.51 |
| 2025-12-31 | 5.77 |
| 2025-09-30 | 7.19 |
| 2025-06-30 | 7.86 |
| 2025-03-31 | 7.74 |
| 2024-12-31 | 8.01 |
| 2024-09-30 | 5.07 |
| 2024-06-30 | 6.49 |
| 2024-03-31 | 7.44 |
| 2023-12-31 | 6.77 |
| 2023-09-30 | 7.89 |
| 2023-06-30 | 5.21 |
| 2023-03-31 | 6.36 |
| 2022-12-31 | 6.92 |
| 2022-09-30 | 9.74 |
| 2022-06-30 | 15.27 |
| 2022-03-31 | 19.98 |
| 2021-12-31 | 19.27 |
| 2021-09-30 | 23.19 |
| 2021-06-30 | 12.05 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 7.08 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
